Banner Overview Tm

TransEnterix sells first Senhance Robotic System to Florida Hospital. Is SurgiBot up Next?

November 13, 2017 • 3 min read

TransEnterix continues to impress. Exactly one month since FDA clearance, TransEnterix announced their first U.S. sale of their Senhance robotic system.

Continue reading

Screen Shot 2017 11 08 At 11 33 45 Am

What was a Surgeon's First Impression of the Senhance Robotic System?

November 08, 2017 • 3 min read

TransEnterix used a great opportunity to make a splash launching their FDA cleared, Senhance Robotic System, at the recent American College of Surgeons (ACS) meeting in San Diego, CA.

Continue reading

Medtronic Stent Hero

Will New Stent Study Negatively Impact Boston Scientific and Medtronic?

November 07, 2017 • 3 min read

Late last week, The Lancet, published an eye opening study concluding that stents fail to ease chest pain. As one cardiologist put it, the results were "unbelievable."

Continue reading

Propel Mini Device Cropped

Intersect ENT's Sinus Implant Proves Effective, But Is It Too Expensive?

November 06, 2017 • 2 min read

Start-up reps fortunate enough to sell a great product hear the cost objection from surgeons all the time. "The product is great, but it is too expensive" Well, here we go again.

Continue reading

Trxcsenhance

Don't Overlook This Major Difference Between Intuitive Surgical and TransEnterix

November 01, 2017 • 2 min read

Where can you look to find a major difference between TransEnterix and Intuitive Surgical?

Continue reading

Mazor Hero

Medtronic and Mazor Robotics Need Each Other

October 31, 2017 • 2 min read

Let's just get this out of the way: Mazor wants to grow and Medtronic needs to infuse growth into their Spine business. In other words, an acquisition does not need to happen in order for this relationship to work.

Continue reading

Entellus Latera Hero

Entellus Medical Announces 24 Month Data on Latera Nasal Implant

October 30, 2017 • 2 min read

Entellus CEO, Bob White, announced the 24 month data from its first-in-human study of the Latera absorbable nasal implant from Spirox.

Continue reading

Celgene Hero

Celgene getting crushed after poor earnings, guidance

October 26, 2017 • 3 min read

The response is to be expected when such an important industry stock misses analysts Q3 projections by 4% and cut 2020 guidance by 5% - 10%.

Continue reading

Sarepta Hero

Sarepta Therapeutics Raises Guidance and Updated Investor Presentation

October 26, 2017 • 3 min read

Yesterday, Sarepta Therapeutics announced third quarter 2017 EXONDYS 51® (eteplirsen) total net revenues of $46 million and raised their 2017 revenue guidance to between $150 million and $155 million.

Continue reading

Tablets Cocktail Cocktail Tablets Drugs

Aurinia Pharmaceuticals Corporate Presentation and Company Profile

October 23, 2017 • 2 min read

We are always looking to help inform our medtechy community members of up and coming biotech and medtech companies. One of the most popular clinical stage companies is Aurinia Pharmaceuticals. Aurinia is focused on developing and commercializing

Continue reading

Next Page